Hee Kyung Ahn

4.1k total citations
171 papers, 2.7k citations indexed

About

Hee Kyung Ahn is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Hee Kyung Ahn has authored 171 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Oncology, 85 papers in Pulmonary and Respiratory Medicine and 22 papers in Surgery. Recurrent topics in Hee Kyung Ahn's work include Lung Cancer Treatments and Mutations (43 papers), Lung Cancer Research Studies (21 papers) and Advanced Breast Cancer Therapies (16 papers). Hee Kyung Ahn is often cited by papers focused on Lung Cancer Treatments and Mutations (43 papers), Lung Cancer Research Studies (21 papers) and Advanced Breast Cancer Therapies (16 papers). Hee Kyung Ahn collaborates with scholars based in South Korea, United States and Japan. Hee Kyung Ahn's co-authors include Young Saing Kim, Eun Kyung Cho, Inkeun Park, Eun Young Kim, Yu Mi Jeong, Sun Jin Sym, Dong Bok Shin, Jeong Ho Kim, Seung Hyup Hyun and Jinny Park and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Hee Kyung Ahn

155 papers receiving 2.7k citations

Peers

Hee Kyung Ahn

ONCOL

PRM

RNMI

PHYSI

Sercan Aksoy Türkiye

Mototsugu Shimokawa Japan

Francesca De Felice Italy

Glenn Mills United States

Orit Kaidar‐Person Israel

Hans Christiansen Germany

Roberto Passera Italy

Shlomo A. Koyfman United States

Cezar Iliescu United States

Kadri Altundağ Türkiye

Sercan Aksoy Türkiye

Hee Kyung Ahn

1.7k ×1.4

ONCOL

780 ×0.8

PRM

340 ×0.8

RNMI

127 ×0.3

PHYSI

554 ×1.5

Citations per year, relative to Hee Kyung Ahn Hee Kyung Ahn (= 1×) peers Sercan Aksoy

Countries citing papers authored by Hee Kyung Ahn

Since Specialization

Citations

This map shows the geographic impact of Hee Kyung Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hee Kyung Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hee Kyung Ahn more than expected).

Fields of papers citing papers by Hee Kyung Ahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hee Kyung Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hee Kyung Ahn. The network helps show where Hee Kyung Ahn may publish in the future.

Co-authorship network of co-authors of Hee Kyung Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Hee Kyung Ahn. A scholar is included among the top collaborators of Hee Kyung Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hee Kyung Ahn. Hee Kyung Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ahn, Hee Kyung, et al.. (2025). Effects of Varying Caffeine Dosages and Consumption Timings on Cerebral Vascular and Cognitive Functions: A Diagnostic Ultrasound Study. Applied Sciences. 15(4). 1703–1703.

Kim, Seok Won, Jong Han Yu, Se Kyung Lee, et al.. (2025). Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of view. European Journal of Surgical Oncology. 51(8). 110011–110011.

Manich, C. Saura, LA Carey, J. O’Shaughnessy, et al.. (2025). 297O Imlunestrant (Imlu) with or without abemaciclib (Abema) in advanced breast cancer (ABC): A subgroup analysis in CDK4/6 inhibitor (CDK4/6i)-pretreated patients (pts) from EMBER-3. ESMO Open. 10. 104869–104869.

Kim, Eunhye, et al.. (2025). Fast and efficient method for parallel construction of targeted exome and methylome single-stranded DNA sequencing libraries. Scientific Reports. 15(1). 7144–7144.

Kang, Eun Joo, Yaewon Yang, Sang-Ho Lee, et al.. (2024). A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17). ESMO Open. 9(9). 103668–103668. 2 indexed citations

Park, Yeon Hee, Kyung-Hun Lee, Gun Min Kim, et al.. (2024). Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2- metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.. Journal of Clinical Oncology. 42(17_suppl). LBA1002–LBA1002. 1 indexed citations

Lee, Jiyun, Hee Kyung Ahn, Sang‐We Kim, et al.. (2024). Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study. Cancer Medicine. 13(7). e7174–e7174. 1 indexed citations

Lee, Yun‐Gyoo, Eun Joo Kang, Bhumsuk Keam, et al.. (2023). Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01). Cancers. 15(2). 471–471.

Lim, Sun Min, Hee Kyung Ahn, Yun‐Gyoo Lee, et al.. (2023). A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial. Cancer Research and Treatment. 56(1). 37–47. 4 indexed citations

10.

Won, Young‐Woong, Jin‐Hyoung Kang, Jung Hye Kwon, et al.. (2023). A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy. Cancer Research and Treatment. 55(4). 1096–1103. 1 indexed citations

11.

Cho, Byoung Chul, Konstantin Penkov, Igor Bondarenko, et al.. (2023). A phase Ib/II dose expansion study of subcutaneous sasanlimab in patients with locally advanced or metastatic non-small-cell lung cancer and urothelial carcinoma. ESMO Open. 8(4). 101589–101589. 4 indexed citations

12.

Keam, Bhumsuk, Hyun Ae Jung, T.M. Kim, et al.. (2023). 1338P Cerebrospinal fluid pharmacokinetic study of lazertinib and pemetrexed in patients with EGFR-mutant non-small cell lung cancer with leptomeningeal metastases: KCSG21-01 LAZARUS trial. Annals of Oncology. 34. S771–S772. 1 indexed citations

13.

An, Ho Jung, Hyun Jeong Jeon, Sang Hoon Chun, et al.. (2022). Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer. Supportive Care in Cancer. 30(9). 7431–7438. 2 indexed citations

14.

Kim, Hong-Sik, Dong‐Wan Kim, Miso Kim, et al.. (2021). Long‐term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real‐world data (KCSG LU20‐11). Cancer. 128(4). 778–787. 30 indexed citations

15.

Kim, Young Saing, Inkeun Park, Hee Kyung Ahn, et al.. (2021). Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy. American Journal of Clinical Oncology. 44(6). 232–238. 5 indexed citations

16.

Lee, Jong Soo, Eun Young Kim, Kwang Gi Kim, et al.. (2021). Longitudinal changes in skeletal muscle mass in patients with advanced squamous cell lung cancer. Thoracic Cancer. 12(11). 1662–1667. 12 indexed citations

17.

Lee, Soo Hyun, Seock‐Ah Im, Gun Min Kim, et al.. (2020). Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10). Cancers. 12(11). 3265–3265. 13 indexed citations

18.

Sym, Sun Jin, et al.. (2019). Concordance Assessment and Satisfaction of Medical Professionals for the Artificial Intelligence Watson. 7(2). 112–118. 1 indexed citations

19.

Kim, Young Saing, Eun Kyung Cho, Junshik Hong, et al.. (2015). Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer. Cancer Research and Treatment. 48(1). 80–87. 13 indexed citations

20.

Park, Jong Sup, Eun Seong Hwang, Sue Nie Park, et al.. (1997). Physical Status and Expression of HPV Genes in Cervical Cancers. Gynecologic Oncology. 65(1). 121–129. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact